Anti-IL-5 [Sch 55700 (Reslizumab)]
AB04156-13.12-BT
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetIL5
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IL-5 [Sch 55700 (Reslizumab)]
- Delivery Days Customer9
- Antibody SpecificityThis antibody recognizes and binds human interleukin-5, a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils. This antibody specifically recognizes amino acids 89-93 (ERRRV) of human IL-5 and is c
- Application Supplier NoteThis antibody is a humanized version of anti-IL5 rat antibody 39D10. The binding affinity of the original human IgG4 version of this antibody was measured using Biacore analysis and it was reported that this antibody bound human IL-5 with a Kd= 81pM (PMID: 7613159). This antibody was capable of inhibiting the binding of hIL-5 to Ba/F3 cells and IL5 induced proliferation of human erythroleukemic cell line TF-1 with an EC50 of 45pM. The in vivo activity of this antibody was studied in Ascaris responsive monkeys, and it was reported that this antibody inhibits eosinophilia in allergic animal models with an extended biological duration (PMID: 7613159). This antibody was active against lung eosinophilia in allergic monkeys and mice and against pulmonary eosinophilia and airway hyperresponsiveness in allergic guinea pigs. It was reported that this antibody did not cause immunosuppression in guinea pigs (PMID: 9698918). It also blocks the pulmonary eosinophilia and neutrophilia caused by tracheal injection of hIL-5 in guinea pigs. In allergic rabbits, this antibody blocks cutaneous eosinophilia. In allergic cynomolgus monkeys, a single dose of this antibody (0.3 mg/kg i.v.) blocks the pulmonary eosinophilia caused by antigen challenge for up to six months (PMID: 10514907). A study was also conducted to determine the effect of this antibody in patients with severe persistent asthma (PMID: 12649124). Clinical trials were conducted with this antibody to reduce asthma exacerbations, control asthma-related symptoms and improve pulmonary function in patients with eosinophilic asthma (PMID: 26372797).
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSch 55700 (Reslizumab)
- Gene ID3567
- Target nameIL5
- Target descriptioninterleukin 5
- Target synonymsB-cell differentiation factor I; colony-stimulating factor, eosinophil; EDF; eosinophil differentiation factor; IL-5; interleukin-5; T-cell replacing factor; TRF
- HostHuman
- IsotypeIgG4
- Protein IDP05113
- Protein NameInterleukin-5
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203